(PharmaNewsWire.Com, June 30, 2020 ) Market Overview• The Global Veno-Venous extracorporeal Life Support (VV ECLS) Devices Market is expected to grow at a high CAGR during the forecasting period (2020-2027).• Extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO),...
North Africa Critical Care Equipment Market(PharmaNewsWire.Com, July 01, 2020 ) The North Africa Critical Care Equipment Market is expected to reach $2.61 billion, at a CAGR of 8.0% during the forecast period.Continuous technological advancements in critical care devices, increasing government support,...
(PharmaNewsWire.Com, June 30, 2020 ) Market Overview• The Global Uveitis Treatment Market is expected to grow at a CAGR of 5.9% in the forecast period 2020-2027.• Uveitis is an inflammation of the middle layer of an eye (uvea), also known as the uveal tract. Auto-immune disorders, injuries, inflammatory...
Viral Inactivation Market(PharmaNewsWire.Com, July 01, 2020 ) The Global Viral Inactivation Market is poised to grow at a CAGR of 12.3%, to reach USD 573.0 Million.Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical...
(PharmaNewsWire.Com, June 30, 2020 ) Market Overview• The worldwide market for Treprostinil Drugs is expected to grow at a CAGR of 4.5% during the forecasting period (2020-2027).• Treprostinil is a vasodilator/ synthetic analog of prostacyclin that is used for the treatment of pulmonary arterial...
(PharmaNewsWire.Com, June 30, 2020 ) Market Overview• The Global Toxoid Vaccine Market is expected to grow at a CAGR of 4.9% during the forecasting period (2020-2027).• Toxoid vaccines are made from a toxin (poison) that has been made harmless but that elicits an immune response against the toxin...
(PharmaNewsWire.Com, June 30, 2020 ) Market Overview• The Global Tourette Syndrome Market is expected to grow at a high CAGR during the forecasting period (2020-2027).• Tourette syndrome is a neurological disorder characterized by repetitive, stereotyped, involuntary movements, and vocalizations...
(PharmaNewsWire.Com, June 30, 2020 ) Market Overview• The Global Thalassemia Treatment Market is expected to grow at a CAGR of 10.5% during the forecasting period (2020-2027).• Thalassemia is an inherited blood disorder that reduces the production of functional hemoglobin, the protein in red blood...
(PharmaNewsWire.Com, June 30, 2020 ) Market Overview• The Global Temperature Management (Therapeutic Hypothermia) Market is expected to grow at a CAGR of 3.5% during the forecasting period (2020-2027). Therapeutic hypothermia, also known as targeted temperature management or protective hypothermia,...
(PharmaNewsWire.Com, June 30, 2020 ) Market Overview• The Global Stomach cancer treatment Market is expected to grow at a CAGR of 5.2% during the forecasting period (2020-2027).• Stomach cancer is a disease in which malignant (cancer) cells form in the lining of the stomach. Stomach cancer usually...
(PharmaNewsWire.Com, June 30, 2020 ) Market Overview• The Global Spinocerebellar Ataxia Market is expected to grow at a high CAGR during the forecasting period (2020-2027).• Spinocerebellar ataxia is a genetic disorder that is progressive, degenerative, and often fatal. The clinical marker of all...
(PharmaNewsWire.Com, June 30, 2020 ) Market Overview• The Global Spinal cord stimulation Market is expected to grow at a CAGR of 8.3% during the forecasting period (2020-2027).• Neuromodulation is an emerging therapy involving targeted delivery of electromagnetic or chemical stimulation to a specific...
(PharmaNewsWire.Com, July 01, 2020 ) Globally, the demand for donated blood is increasing because of greater volume of sophisticated medical surgical procedures conducted and the increasing number of trauma cases due to road accidents. These procedures require blood transfusions to make up for blood...
(PharmaNewsWire.Com, June 30, 2020 ) Market Overview• The Global Scleroderma Therapeutics Market is expected to grow at a CAGR of 5.89% during the forecasting period (2020-2027).• Scleroderma, or systemic sclerosis, is a chronic connective tissue disease generally classified as one of the autoimmune...
(PharmaNewsWire.Com, July 01, 2020 ) Growth in this market is majorly driven by the increasing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology R&D, the increasing prevalence of cancer and other chronic and infectious diseases,...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
